| Ryan Mcenrue Kiefer, MD | |
|
1 Medical Center Dr, Lebanon, NH 03756-0001 | |
| (603) 650-5000 | |
| Not Available |
| Full Name | Ryan Mcenrue Kiefer |
|---|---|
| Gender | Male |
| Speciality | Radiology - Vascular & Interventional Radiology |
| Location | 1 Medical Center Dr, Lebanon, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578068540 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Ryan Mcenrue Kiefer, MD 1 Medical Center Dr, Lebanon, NH 03756-0001 Ph: (603) 650-5000 | Ryan Mcenrue Kiefer, MD 1 Medical Center Dr, Lebanon, NH 03756-0001 Ph: (603) 650-5000 |
News Archive
A team of researchers based in Stockholm, Sweden, has demonstrated that individuals exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have antibodies for the disease up to nine months after acquiring the disease, even if they displayed only mild symptoms.
Researchers at Karolinska Institutet in Sweden have identified a biological circadian clock in the hearing organ, the cochlea. This circadian clock controls how well hearing damage may heal and opens up a new way of treating people with hearing disabilities.
Some privacy advocates say the government is seeking to move too quickly to digitize health records, and may risk exposing sensitive information to identity thieves and hackers. These privacy advocates appear to favor slow progress is spreading electronic records because - they hope - consumer safeguards can keep up with that pace.
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
TomoTherapy Incorporated (NASDAQ: TOMO) announced today that there will be more than 40 presentations at the 10th Biennial ESTRO Conference on Physics and Radiation Technology for Clinical Radiotherapy that explore use of the TomoTherapy® treatment system. The TomoTherapy system - a versatile, CT scanner-based device that integrates image guidance for increased treatment accuracy and helical radiation therapy delivery for enhanced tumor targeting - is helping cancer centers advance patient care around the world.
› Verified 7 days ago
Thomas Ray Burdick, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
William B. Zucconi, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
Dr. Thomas Francis Delaney, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-6600 | |
Dr. Jessica Margaret Sin, M.D., PH.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Dr, Lebanon, NH 03756 Phone: 603-650-7650 | |
Dr. Harlan G Herr, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-7650 | |
Matthew E Maeder, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-4371 | |
Dr. Judith Austin-strohbehn, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Department Of Radiology, Lebanon, NH 03756 Phone: 603-650-4477 Fax: 603-650-5455 |